• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Critical appraisal and narrative review of the literature in IVF/ICSI patients with adenomyosis and endometriosis.对患有子宫腺肌病和子宫内膜异位症的体外受精/卵胞浆内单精子注射患者的文献进行批判性评价和叙述性综述。
Front Reprod Health. 2024 Dec 24;6:1525705. doi: 10.3389/frph.2024.1525705. eCollection 2024.
2
Reduced live birth rates following ART in adenomyosis patients: a matched control study.子宫腺肌病患者接受辅助生殖技术后活产率降低:一项配对对照研究。
Hum Reprod. 2025 May 1;40(5):855-864. doi: 10.1093/humrep/deaf052.
3
In vitro fertilization and multiple pregnancies: an evidence-based analysis.体外受精与多胎妊娠:一项基于证据的分析。
Ont Health Technol Assess Ser. 2006;6(18):1-63. Epub 2006 Oct 1.
4
Untangling the independent effect of endometriosis, adenomyosis, and ART-related factors on maternal, placental, fetal, and neonatal adverse outcomes: results from a systematic review and meta-analysis.梳理子宫内膜异位症、子宫腺肌病和与 ART 相关因素对母婴、胎盘、胎儿和新生儿不良结局的独立影响:系统评价和荟萃分析的结果。
Hum Reprod Update. 2024 Dec 1;30(6):751-788. doi: 10.1093/humupd/dmae024.
5
Women with combined adenomyosis and endometriosis on MRI have worse IVF/ICSI outcomes compared to adenomyosis and endometriosis alone: A matched retrospective cohort study.MRI 显示合并子宫腺肌病和子宫内膜异位症的女性与单纯子宫腺肌病和子宫内膜异位症相比,体外受精/卵胞浆内单精子注射(IVF/ICSI)结局更差:一项匹配的回顾性队列研究。
Eur J Obstet Gynecol Reprod Biol. 2022 Apr;271:223-234. doi: 10.1016/j.ejogrb.2022.02.026. Epub 2022 Feb 24.
6
Presence of adenomyosis at MRI reduces live birth rates in ART cycles for endometriosis.MRI 显示存在子宫腺肌病会降低子宫内膜异位症患者 ART 周期的活产率。
Hum Reprod. 2022 Jun 30;37(7):1470-1479. doi: 10.1093/humrep/deac083.
7
Peri-implantation treatment with TNF-α inhibitor for endometriosis and/or adenomyosis women undergoing frozen-thawed embryo transfer: A retrospective cohort study.子宫内膜异位症和/或子宫腺肌病患者冻融胚胎移植围植入期使用肿瘤坏死因子-α抑制剂治疗:一项回顾性队列研究。
J Reprod Immunol. 2025 Feb;167:104415. doi: 10.1016/j.jri.2024.104415. Epub 2024 Dec 11.
8
Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI.子宫腺肌病不会对长期垂体下调预处理的子宫内膜异位症患者行 IVF/ICSI 治疗的结局产生不良影响。
Eur J Obstet Gynecol Reprod Biol. 2010 Jul;151(1):62-5. doi: 10.1016/j.ejogrb.2010.02.047. Epub 2010 Apr 21.
9
Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer.腺肌症和内异症对 GnRH 激动剂治疗后冻融胚胎移植患者 IVF/ICSI 妊娠结局的影响。
Sci Rep. 2023 Apr 25;13(1):6741. doi: 10.1038/s41598-023-34045-7.
10
Medical treatment before in-vitro fertilization in patients with adenomyosis: a systematic review and meta-analysis.子宫腺肌病患者体外受精前的医学治疗:系统评价与荟萃分析。
J Assist Reprod Genet. 2025 Feb;42(2):381-388. doi: 10.1007/s10815-024-03323-2. Epub 2024 Dec 12.

本文引用的文献

1
Functional determinants of uterine contractility in endometriosis and adenomyosis: a systematic review and meta-analysis.子宫内膜异位症和子宫腺肌病中子宫收缩力的功能决定因素:一项系统评价和荟萃分析。
Fertil Steril. 2024 Dec;122(6):1063-1078. doi: 10.1016/j.fertnstert.2024.07.026. Epub 2024 Jul 25.
2
Internal and external adenomyosis phenotypes: ultrasound features and association with clinical outcomes.子宫腺肌病的内外表型:超声特征及其与临床结局的关联
Hum Reprod. 2024 May 22. doi: 10.1093/humrep/deae105.
3
Live Birth After Oocyte Donation In Vitro Fertilization Cycles in Women With Endometriosis: A Systematic Review and Meta-Analysis.《子宫内膜异位症患者行体外受精-胚胎移植周期中卵母细胞捐赠后的活产率:系统评价和荟萃分析》。
JAMA Netw Open. 2024 Jan 2;7(1):e2354249. doi: 10.1001/jamanetworkopen.2023.54249.
4
Impact of adenomyosis on in vitro fertilization outcomes in women undergoing donor oocyte transfers: a prospective observational study.腺肌病对供卵试管婴儿结局的影响:一项前瞻性观察性研究。
Fertil Steril. 2024 Mar;121(3):480-488. doi: 10.1016/j.fertnstert.2023.11.034. Epub 2023 Dec 1.
5
Different subtypes of ultrasound-diagnosed adenomyosis and in vitro fertilization outcomes: A systematic review and meta-analysis.不同亚型的超声诊断的子宫腺肌病与体外受精结局:系统评价和荟萃分析。
Acta Obstet Gynecol Scand. 2023 Jun;102(6):657-668. doi: 10.1111/aogs.14580. Epub 2023 Apr 20.
6
Endometriosis and adenomyosis: shared pathophysiology.子宫内膜异位症和子宫腺肌病:共同的发病机制。
Fertil Steril. 2023 May;119(5):746-750. doi: 10.1016/j.fertnstert.2023.03.006. Epub 2023 Mar 15.
7
Prevalence of adenomyosis in women with subfertility: systematic review and meta-analysis.不孕症妇女中子宫腺肌病的患病率:系统评价和荟萃分析。
Ultrasound Obstet Gynecol. 2023 Jul;62(1):23-41. doi: 10.1002/uog.26159. Epub 2023 Apr 28.
8
Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis.腺肌症患者行 IVF/ICSI 中 GnRH 拮抗剂方案冻融与长效 GnRH 激动剂方案比较:倾向评分匹配分析。
BMC Pregnancy Childbirth. 2022 Dec 17;22(1):946. doi: 10.1186/s12884-022-05276-9.
9
Adjustment of progesterone administration after endometrial transcriptomic analysis does not improve reproductive outcomes in women with adenomyosis.子宫内膜转录组分析后调整孕酮给药并不能改善子宫腺肌病女性的生殖结局。
Reprod Biomed Online. 2023 Jan;46(1):99-106. doi: 10.1016/j.rbmo.2022.09.007. Epub 2022 Sep 15.
10
The effect of endometriosis on IVF/ICSI and perinatal outcome: A systematic review and meta-analysis.子宫内膜异位症对 IVF/ICSI 及围产结局的影响:系统评价和荟萃分析。
J Gynecol Obstet Hum Reprod. 2022 Nov;51(9):102446. doi: 10.1016/j.jogoh.2022.102446. Epub 2022 Jul 26.

对患有子宫腺肌病和子宫内膜异位症的体外受精/卵胞浆内单精子注射患者的文献进行批判性评价和叙述性综述。

Critical appraisal and narrative review of the literature in IVF/ICSI patients with adenomyosis and endometriosis.

作者信息

Mercan Ramazan, Benlioglu Can, Aksakal Gulumser Ece

机构信息

Department of Obstetrics and Gynecology, School of Medicine, Koc University, İstanbul, Türkiye.

Department of Obstetrics and Gynecology, American Hospital, İstanbul, Türkiye.

出版信息

Front Reprod Health. 2024 Dec 24;6:1525705. doi: 10.3389/frph.2024.1525705. eCollection 2024.

DOI:10.3389/frph.2024.1525705
PMID:39777049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11703904/
Abstract

Endometriosis and adenomyosis are prevalent causes of infertility, often coexisting in a significant proportion of patients. Although endometriosis typically does not negatively impact assisted reproductive technology (ART) outcomes, the presence of coexisting adenomyosis, mainly non-severe external forms, may slightly influence IVF/ICSI success rates. However, this impact is often minimal and may result in insignificant changes in statistical analyses. Recent studies underscore the critical role of accurate diagnostic techniques, such as ultrasound or MRI, in identifying severe adenomyosis characteristics, including diffuse involvement with junctional zone participation. This precise delineation is reassuring, as it is essential for tailoring assisted reproductive technology (ART) strategies to enhance success rates and reduce the confounding effects of adenomyosis, particularly when it coexists with endometriosis. Strategic approaches, such as ultralong GnRH agonist protocols or freeze-all strategies, may provide advantages in these scenarios. However, the need for extensive research is vital to understanding the complex interactions between endometriosis, adenomyosis, and ART outcomes. This ongoing exploration is particularly important in cases where coexisting adenomyosis might not significantly influence statistical results.

摘要

子宫内膜异位症和子宫腺肌病是导致不孕的常见原因,在相当一部分患者中常常并存。虽然子宫内膜异位症通常不会对辅助生殖技术(ART)的结果产生负面影响,但并存子宫腺肌病,主要是非严重的外在形式,可能会对体外受精/卵胞浆内单精子注射(IVF/ICSI)成功率产生轻微影响。然而,这种影响通常很小,可能在统计分析中导致不显著的变化。最近的研究强调了准确的诊断技术,如超声或磁共振成像(MRI),在识别严重子宫腺肌病特征方面的关键作用,包括弥漫性累及伴交界区参与。这种精确的描述令人放心,因为它对于制定辅助生殖技术(ART)策略以提高成功率和减少子宫腺肌病的混杂影响至关重要,特别是当它与子宫内膜异位症并存时。诸如超长促性腺激素释放激素(GnRH)激动剂方案或全冻策略等策略在这些情况下可能具有优势。然而,进行广泛研究对于理解子宫内膜异位症、子宫腺肌病和ART结果之间的复杂相互作用至关重要。在并存子宫腺肌病可能不会显著影响统计结果的情况下,这种持续的探索尤为重要。